China failed to speed up ag biotech review process

Despite a pledge in early 2020 to do so, China has not shortened the average time — more than two years — that it takes to decide whether to approve agricultural biotechnology products for import, said the Biden administration in an annual review. The slow-moving process disrupts U.S. farm exports and the commercialization of new… » Read More

The Ag Insider content is only available to members.
Exit mobile version